Valuation: Seer, Inc.

Market Cap 91.27M 79.89M 73.75M 68.79M 130M 8.63B 132M 885M 343M 4.26B 343M 335M 14.84B P/E 2026 *
-1.59x
P/E 2027 * -1.69x
Enterprise Value 91.27M 79.89M 73.75M 68.79M 130M 8.63B 132M 885M 343M 4.26B 343M 335M 14.84B EV / Sales 2026 *
5.62x
EV / Sales 2027 * 4.36x
Free-Float
85.52%
Yield 2026 *
-
Yield 2027 * -
1 week-4.05%
1 month-11.23%
3 months-1.19%
6 months-9.29%
Current year-9.29%
1 week 1.66
Extreme 1.66
1.76
1 month 1.66
Extreme 1.66
1.89
Current year 1.65
Extreme 1.65
2.2
1 year 1.65
Extreme 1.65
2.41
3 years 1.46
Extreme 1.455
5.65
5 years 1.46
Extreme 1.455
45.85
10 years 1.46
Extreme 1.455
86.55
Manager TitleAgeSince
Chief Executive Officer 57 2018-02-28
Director of Finance/CFO 58 2020-04-30
Chief Operating Officer - -
Director TitleAgeSince
Chairman 57 2020-08-31
Director/Board Member 76 2017-11-30
Director/Board Member 70 2017-11-30
Date Insider Type Main position Quantity % Market Cap.
05-19Sell

Chief Financial Officer

-7,303 0.0129%
05-07Free

Executive/Senior Manager

300,000 0.5317%
02-17Sell

Chief Financial Officer

7,743 0.0150%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-4.05%-22.43%-61.12% 91.27M
+1.48%+10.45%+8.75%-2.60% 25.82B
-1.04%+6.87%+16.17%-9.61% 7.32B
+20.00%+38.40%+141.12%+261.25% 5.37B
+7.43%+9.69%+214.23%+172.24% 2.7B
+6.33%+11.11%+7.32%-48.82% 2.51B
+3.78%+21.64%+68.23%+83.92% 2.4B
+4.30%+10.31%+78.83%+49.74% 2.23B
+2.26%+1.02%-12.96%+32.25% 1.12B
+0.09%-1.04%+124.49%+68.83% 992M
Average +4.48%+5.92%+62.37%+54.61% 5.05B
Weighted average by Cap. +3.87%+8.93%+42.43%+39.92%

Financials

2026 *2027 *
Net sales 16.25M 14.22M 13.13M 12.25M 23.08M 1.54B 23.49M 157M 61.14M 758M 61.05M 59.69M 2.64B 20.95M 18.34M 16.93M 15.79M 29.75M 1.98B 30.28M 203M 78.83M 977M 78.71M 76.95M 3.41B
Net income -58.65M -51.34M -47.39M -44.2M -83.29M -5.55B -84.78M -568M -221M -2.74B -220M -215M -9.53B -55.7M -48.75M -45.01M -41.98M -79.1M -5.27B -80.51M -540M -210M -2.6B -209M -205M -9.05B
Net Debt - -
Logo Seer, Inc.
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
Employees
124
Date Price Change Volume
26-06-30 US$1.660 -.--% 169,094
26-06-29 US$1.660 -.--% 218,182
26-06-26 US$1.660 -4.05% 438,858
26-06-25 US$1.730 +2.37% 90,161
26-06-24 US$1.690 -2.31% 118,090
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.660USD
Average target price
4.000USD
Spread / Average Target
+140.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEER Stock